Cost-effectiveness of Population-Based Mutation Testing Cost-effectiveness of Population-Based Mutation Testing

Is population-based testing for breast and ovarian cancer gene mutations more cost-effective than family history-based BRCA testing?Journal of the National Cancer Institute
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news